(PRWEB) February 13, 2013
Pollogen Ltd., a global leader in the medical aesthetics market, announced that it has entered into an exclusive partnership with CDM Medical. CDM Medical, is a veteran expert in marketing and selling high-end medical devices and wellness equipment to both the public and private sectors in Chile. CDM Medical will be responsible for integrating Pollogen solutions treatments into aesthetic clinics and medi-spas as well as providing all clinical and technical support for Pollogen’s professional systems.
Pollogen’s offerings in Chile will include recently released Hybrid Energy Technology- a breakthrough concept that delivers Dermal Volumizing, reduction of wrinkles and mini facelift effects without surgery, discomfort or downtime.
Hybrid Energy’s key advantage is the unique combination of Hot and Electrical Invisible Micro Ablation (IMA) which are administered via a disposable tip comprised of an array of micro pins.
Hot IMA facilitates smooth and painless penetration of the micro pins to target the mid dermis. Electrical IMA then selectively affects the target area using safe non-thermal energy. This creates micro-wounds in the dermis and triggers the body’s natural healing response mechanism in a safe process, with none to minimal pain and no down time. As a result, while epidermal visible response is minimized, a significant effect is generated in the Dermis that delivers Auto-production of Hyaluronic Acid, Collagen Regeneration and Elastin Growth.
TriLipo technology combines two technologies delivered simultaneously: Focused TriLipo RF for thermal effect and TriLipo DMA for internal muscles activation.
Patients and practitioners benefit from the use of simultaneous multiple technologies at once. This novel technology provides a unique non-invasive alternative to surgical procedures for body shaping. Following the treatment, patients experience visible immediate and long-lasting results. Body contouring is achieved by reducing and removing subcutaneous fat and skin tightening via collagen remodeling.
All of Pollogen's solutions are clinically proven and safe as well as being suitable for all skin types and colors.
Mr. Carlos Di Meglio, General Manager of CDM Medical: “We are delighted to be working with Pollogen. Pollogen’s technologies are a global industry standard and we are confident that these effective solutions will be quickly adopted by the medical aesthetic community in Chile. Many leading physicians are already familiar with Pollogen and are excited about their innovative technological advancements. ”
Pollogen ‘s CEO Mr. Amichai Bar-Nir:
“We look forward to working with CDM Medical and are confident that their expertise and knowledge of the Chilean market are a good fit for us. We appreciate their enthusiasm for our products and value their experience and professionalism."
We believe in thinking differently.
We believe in constantly challenging ourselves to create the most advanced, effective medical aesthetic technologies and solutions.
In everything we do, Pollogen takes a customer-centric approach by making our products user-friendly, safe and convenient. At Pollogen there is no such word as “done”; we continually perfect our solutions so that our solutions provide treatments that are pleasant and effective. We believe in finding ways to develop technologies that work with the body’s natural mechanisms so beautiful results are generated from within.
Pollogen is the developer and manufacturer of five revolutionary technologies under the industry premier brand names OxyGeneo™, Hybrid Energy™, TriPollar®, TriLipo® andTriFractional™.
We offer a full line of clinically-proven, safe and effective, non-invasive anti-aging facial and body contouring treatment platforms for a wide range of aesthetic applications. Pollogen provides solutions for professionals in over 60 countries, addressing the specific needs and dynamic changes unique to the ever-evolving aesthetic industry.